We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
FIGURE 1

FIGURE 1. From: Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents.

Flow of Participants in a Study Comparing Fluoxetine and Placebo in Preventing Relapse of Major Depression in Children and Adolescents

Graham J. Emslie, et al. Am J Psychiatry. ;165(4):459-467.
2.
FIGURE 3

FIGURE 3. From: Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents.

Survival Curve Showing Time to Full Relapse for Children and Adolescents Receiving Fluoxetine or Placebo in Continuation Treatment After Response in Acute Treatment With Fluoxetine a
a Full relapse was defined as a Children’s Depression Rating Scale—Revised (CDRS-R) score ≥40. The survival model was adjusted for the following covariates: gender, age, race, duration of episode, number of episodes, duration of illness, age at illness onset, and baseline continuation phase scores for the CDRS-R, CGI severity scale, Children’s Global Assessment Scale, and Family Global Assessment Scale.

Graham J. Emslie, et al. Am J Psychiatry. ;165(4):459-467.
3.
FIGURE 2

FIGURE 2. From: Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents.

Survival Curve Showing Time to Relapse for Children and Adolescents Receiving Fluoxetine or Placebo in Continuation Treatment After Response in Acute Treatment With Fluoxetine a
a Relapse was defined as either a one-time score ≥40 on the Children’s Depression Rating Scale—Revised (CDRS-R) with worsening of depressive symptoms for at least 2 weeks, or a clinician determination that significant clinical deterioration suggested that full relapse would be likely without altering treatment, even if the CDRS-R score was <40. The survival model was adjusted for the following covariates: gender, age, race, duration of episode, number of episodes, duration of illness, age at illness onset, and baseline continuation phase scores for the CDRS-R, Clinical Global Impression severity scale, Children’s Global Assessment Scale, and Family Global Assessment Scale.

Graham J. Emslie, et al. Am J Psychiatry. ;165(4):459-467.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk